These results suggest that HQD may activate anti-tumor immune responses by inhibiting the differentiation of CD8+ T cells toward exhausted and immunosuppressive phenotypes, thereby combating the malignant progression of CRC liver metastasis. Here, CD8A is linked to neoplasm.